XTalks

JUNE 8, 2021

SMA is a rare genetic condition that leads to a loss of motor neurons that results in progressive muscle weakness and wasting, paralysis and, when left untreated in its most severe form, breathing difficulties leading to permanent ventilation or death for most patients by the age of two. With a price tag of over $2.5

Gene Therapy 110

Gene Therapy Gene Protein Trials 110

pharmaphorum

SEPTEMBER 12, 2022

Across LabCorp , we innovate through science and technology, with access to approximately 2,500 [doctors] and PhDs and over 700 patients. Everyone’s genetic makeup differs, and each person’s cancer experience is unique to them – how cancer develops, how fast it spreads, which drugs it responds to, and more. Tailored oncology.

Genome 105

Genome Genomics Clinical Trials Clinical Trials 105

XTalks

APRIL 6, 2022

Register for this webinar to get an overview of the role of long non-protein coding RNAs (lncRNAs) in gene regulations. If that happens, it is a big setback for patients and the doctors treating them,” said Dr. Rosenfeld in a news release by Cancer Research UK. Live and On-Demand: Thursday, April 21, 2022, at 11am EDT (4pm BST/UK).

DNA 105

DNA In-Vitro Doctors Doctor 105

pharmaphorum

JANUARY 29, 2021

This has, of course, garnered immense excitement – Doctors Emmanuelle Charpentier and Jennifer Doudna were named winners of the Nobel Prize for chemistry in recognition of their discovery of CRISPR/Cas9 gene editing technology. And ultimately we will be able to add genetic influences to diseases that don’t have a genetic cause.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

SEPTEMBER 9, 2020

Charlie told pharmaphorum how his search for a genetic cause has led him to straddle the divide between scientist and patient advocate. He is currently the patient advocacy and engagement lead at Congenica, a digital health company that is investigating the genetic basis of rare diseases. For some people, a job is more than just a job.

Genome 102

Genome Genomics Genetics Genome Project 102

pharmaphorum

AUGUST 1, 2022

Sarepta’s gene therapy – like rivals from Pfizer and Solid Biosciences – codes for a shortened form of the dystrophin protein that is deficient in patients with the X-linked muscle-wasting disease, which occurs primarily in males.

Gene Therapy 105

Gene Therapy Gene Genetics Trials 105

The Pharma Data

JANUARY 11, 2021

They give the body a blueprint to create a bit of the virus that causes COVID-19, called a spike protein. Once you are vaccinated, the cell’s machinery uses the blueprint to make the spike protein. This protein then appears on the surface of the cell and the immune system responds to it.

Vaccination 52

Vaccination Vaccine Allergies Protein 52

XTalks

AUGUST 10, 2021

This “SHERLOCK reaction” is designed to cut SARS-CoV-2 RNA at a specific region in the nucleoprotein gene that is conserved across multiple variants of the virus, and which codes for proteins involved in formation of the viral nucleocapsid. A porous membrane was engineered to capture RNA on its surface. miSHERLOCK Workflow.

RNA 105

RNA Containment DNA Engineer 105

pharmaphorum

SEPTEMBER 9, 2020

Charlie told pharmaphorum how his search for a genetic cause has led him to straddle the divide between scientist and patient advocate. He is currently the patient advocacy and engagement lead at Congenica, a digital health company that is investigating the genetic basis of rare diseases. For some people, a job is more than just a job.

Genome 80

Genome Genomics Genetics Genome Project 80

pharmaphorum

AUGUST 23, 2022

To understand how quickly the industry responded, one need only look at the development history of Moderna’s COVID-19 vaccine: the company took all of two days to transition from receiving the genetic sequence of the virus to creating a vaccine candidate.

Vaccine 134

Vaccine Vaccination Development Trials 134

XTalks

JUNE 30, 2023

Hemophilia A is a rare genetic bleeding disorder that is caused by a mutation in the gene that encodes the key blood clotting protein factor VIII (FVIII). Hemophilia A affects approximately one in 10,000 individuals and has a higher incidence than hemophilia B.

Gene Therapy 98

Gene Therapy Gene FDA Approval Antibody 98

pharmaphorum

NOVEMBER 9, 2022

Haemophilia is a rare genetic bleeding disorder, occurring in one in every 5,000 (Haemophilia A) to 30,000 (Haemophilia B) male births, and is associated with an increased bleeding tendency due to a deficiency of blood clotting proteins, called coagulation factors, which are needed for the blood to clot.†. What is haemophilia?

Pharmacy 98

Pharmacy Doctors Doctor Development 98

The Pharma Data

DECEMBER 3, 2020

Dravet syndrome is a severe and progressive genetic epilepsy characterized by frequent, prolonged and refractory seizures that usually begin within the first year of life. December 5, 2:00 PM – 3:30 PM; Platform A: Translational Research / Genetics. Genetics / 12A. –( BUSINESS WIRE )– Stoke Therapeutics , Inc.

Medicine 52

Medicine Genetics Clinical Trials Clinical Trials 52

STAT News

MARCH 6, 2023

But they said the sum covers only the direct costs of designing and manufacturing the vaccines ― which are tailored to the unique genetic makeup of each patient’s tumor ― and that the FDA has approved the breakdown of expenses. Neoantigen vaccines are designed to target certain proteins called neoantigens on tumor cells.

Vaccination 98

Vaccination Vaccine Drugs Clinical Trials 98

XTalks

AUGUST 8, 2024

Tecelra is the first cell therapy engineered for a solid tumor cancer in the US, offering a new option for patients with specific genetic markers who have previously undergone chemotherapy. Tecelra works by using the patient’s own immune system to target tumors expressing the melanoma-associated antigen A4 (MAGE-A4) protein on cancer cells.

Engineer 52

Engineer Clinical Trials Clinical Trials FDA Approval 52

Bioengineer

JULY 23, 2021

. “For the first time, we identified a crucial interaction between platelets and the tumor via their surface proteins,” Jain said. ” Jain’s team in College Station for this research includes postdoctoral researcher Dr. Biswajit Saha and doctoral students Jim Tronolone and Tanmay Mathur.

Engineer 52

Engineer Gene Editing Clinical Trials Clinical Trials 52

Delveinsight

DECEMBER 18, 2020

Some genetic disorders (such as Down syndrome). You should try knowing your triggers to keep a track on it and have a proper response plan made with the help of your doctors. If you have experienced it before, then you can call your doctor to inform him about it. Lack/ loss of oxygen to the brain (especially during birth).

Doctors 52

Doctors Doctor Drugs Development 52

XTalks

FEBRUARY 11, 2021

This has ushered in a new era of genomics that is fostering rapid, detailed and personalized insights into human genetics. Xtalks is celebrating the International Day of Women and Girls in Science with a special overview of notable female scientists who have made revolutionary contributions to the field of genetics. Rosalind Franklin.

Genetics 119

Genetics DNA Genome Genomics 119

The Pharma Data

MAY 15, 2021

Now imagine the entire length of the field as the 300,000 years of human genetic evolution. However your genetic code IS hardwired to go without food for short periods between times of plenty. Especially meals that are high in sugar and protein. Listen: Brad’s not a doctor and neither am I. Picture a football field….

Production 52

Production Hormones Protein Insulin 52

The Pharma Data

OCTOBER 25, 2020

SCD is one of the most prevalent genetic rare diseases in Europe, and despite a clinical understanding of SCD, estimated life expectancy for those affected by the disease is significantly lower than the European average, indicating an urgent need to improve the quality of care for these patients. Some medicines may affect how Oxbryta works.

Medicine 40

Medicine Development Containment FDA Approval 40

The Pharma Data

JUNE 18, 2021

The BTK protein sends important signals that tell B cells to mature and produce antibodies. VENCLEXTA ® /VENCLYXTO ® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein. VENCLXEXTA/VENCLYXTO targets the BCL-2 protein and works to help restore the process of apoptosis.

Medicine 52

Medicine Production FDA Approval Development 52

The Pharma Data

JUNE 18, 2021

The BTK protein sends important signals that tell B cells to mature and produce antibodies. Call your doctor for medical advice about side effects. About VENCLEXTA ® /VENCLYXTO ® (venetoclax) VENCLEXTA ® /VENCLYXTO ® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein.

Medicine 40

Medicine Production FDA Approval Development 40

The Pharma Data

JUNE 18, 2021

The BTK protein sends important signals that tell B cells to mature and produce antibodies. Call your doctor for medical advice about side effects. 4 Genetics Home Reference. BTK signaling is needed by specific cancer cells to multiply and spread. to help reduce your risk of losing too much fluid (dehydration) due to diarrhea.

FDA Approval 40

FDA Approval Medicine Development Trials 40

The Pharma Data

MAY 14, 2021

There are so many people out there telling you to try keto, intermittent fasting, vegan, high-protein, high-fat, low-fat, and so much more. But the reason for my muscular arms has nothing to do with genetics (before starting to lift weights, my arms were as skinny as pipe cleaners). Remember, I’m not genetically gifted in any way.

Production 52

Production Branding Vaccination Vaccine 52

The Pharma Data

MAY 14, 2021

All the scientific studies… And the words straight from a doctor’s mouth… So you’ll have everything you need… By the way, my name is Matt Stirling. It’s all based on human biology… I refer to it as your “metabolism switch”… But the scientific name for it is AMP-activated protein kinase….

Production 52

Production Insulin Packaging Packaging 52

pharmaphorum

DECEMBER 7, 2021

They used computational techniques to sift through genetic and other biologic data as well as insurance claims information from a database of more than 7 million patients, and found that sildenafil had the greatest potential as an Alzheimer’s drug. .”

Drugs 52

Drugs Clinical Trials Clinical Trials Scientist 52

The Pharma Data

JANUARY 21, 2021

Doctors need better tools to evaluate the status of COVID-19 patients as early as possible because many of the treatments—such as monoclonal antibodies—are in short supply, and we know that some patients will get better without intensive treatments,” said co-senior author Andrew E. The research was published in the journal JCI Insight.

Research 52

Research DNA Hormones Vaccination 52

The Pharma Data

MAY 14, 2021

The swelling caused by DHT reduces blood flow and restricts your follicle’s access to proteins, enzymes and hormones that are essential to healthy hair. What’s worse is that I actually listened to doctors when they told me that my hair loss was genetic – and that there was nothing I could do to overcome it.

Production 52

Production Hormones Doctors Doctor 52

pharmaphorum

NOVEMBER 23, 2020

Doctors now have another option to choose from to combat the disease, following EUAs for drugs such as Eli Lilly’s baricitinib and Gilead’s Veklury (remdesivir). Regeneron’s antibodies were designed to combat SARS-CoV-02 using the company’s proprietary genetically modified mice, which have been engineered to have a human immune system.

Antibody 52

Antibody Immune Response Trials Engineer 52

XTalks

NOVEMBER 11, 2021

The COVID-19 vaccine patent is for the specific genetic sequence of the spike protein used in the Spikevax vaccine. NIH says three of its scientists — Dr. John Mascola, Dr. Barney Graham and Dr. Kizzmekia Corbett — assisted in the design of the spike genetic sequence and should, therefore, be included on the patent application.

Vaccination 98

Vaccination Vaccine Scientist Contract Manufacturing 98

The Pharma Data

NOVEMBER 10, 2020

The vaccine uses a technology never before used: Each injection contains lipid nanoparticles — fat bubbles — that surround a strip of genetic material called messenger RNA, the Post reported. The genetic material carries the blueprint for the distinctive spiky protein that protrudes from the virus’ surface.

Antibody 52

Antibody Vaccination Vaccine RNA 52

The Pharma Data

NOVEMBER 9, 2020

The vaccine uses a technology never before used: Each injection contains lipid nanoparticles — fat bubbles — that surround a strip of genetic material called messenger RNA, the Post reported. The genetic material carries the blueprint for the distinctive spiky protein that protrudes from the virus’ surface.

Vaccination 52

Vaccination Vaccine RNA Genetics 52

XTalks

SEPTEMBER 14, 2020

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. The University of Oxford/AstraZeneca partnership, in turn, is testing a viral-vectored coronavirus vaccine that again expresses the spike protein of SARS-CoV-2 virus.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92